Impaired bone anabolic response to parathyroid hormone in Fgf2-/- and Fgf2+/- mice.

Document Type


Publication Date



Bone-and-Bones, Female, Femur, Humans, Male, Mice-Knockout, Osteogenesis, Parathyroid-Hormone, Receptor-Fibroblast-Growth-Factor-Type-2, Recombinant-Proteins, Research-Support-N, I, H, -Extramural, Teriparatide, Tomography-X-Ray-Computed

JAX Source

Biochem Biophys Res Commun 2006; 341(4):989-94.


Since parathyroid hormone (PTH) increased FGF2 mRNA and protein expression in osteoblasts, and serum FGF-2 was increased in osteoporotic patients treated with PTH, we assessed whether the anabolic effect of PTH was impaired in Fgf2-/- mice. Eight-week-old Fgf2+/+ and Fgf2-/- male mice were treated with rhPTH 1-34 (80mug/kg) for 4 weeks. Micro-CT and histomorphometry demonstrated that PTH significantly increased parameters of bone formation in femurs from Fgf2+/+ mice but the changes were smaller and not significant in Fgf2-/- mice. IGF-1 was significantly reduced in serum from PTH-treated Fgf2-/- mice. DEXA analysis of femurs from Fgf2+/+, Fgf2+/-, and Fgf2-/- mice treated with rhPTH (160mug/kg) for 10 days showed that PTH significantly increased femoral BMD in Fgf2+/+ by 18%; by only 3% in Fgf2+/- mice and reduced by 3% in Fgf2-/- mice. We conclude that endogenous Fgf2 is important for maximum bone anabolic effect of PTH in mice.

Please contact the Joan Staats Library for information regarding this document.